APA (7th ed.) Citation

Pfister, K., Schäffler, H., Huesmann, S., Heublein, S., Braun, T., Lukac, S., . . . Fink, A. (2025). Will Minimal Residual Disease Monitoring Be Part of Routine Surveillance? Oncology Research & Treatment, 48(6), 372. https://doi.org/10.1159/000544838

Chicago Style (17th ed.) Citation

Pfister, Kerstin, et al. "Will Minimal Residual Disease Monitoring Be Part of Routine Surveillance?" Oncology Research & Treatment 48, no. 6 (2025): 372. https://doi.org/10.1159/000544838.

MLA (9th ed.) Citation

Pfister, Kerstin, et al. "Will Minimal Residual Disease Monitoring Be Part of Routine Surveillance?" Oncology Research & Treatment, vol. 48, no. 6, 2025, p. 372, https://doi.org/10.1159/000544838.